JP2024099590A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024099590A5 JP2024099590A5 JP2024063716A JP2024063716A JP2024099590A5 JP 2024099590 A5 JP2024099590 A5 JP 2024099590A5 JP 2024063716 A JP2024063716 A JP 2024063716A JP 2024063716 A JP2024063716 A JP 2024063716A JP 2024099590 A5 JP2024099590 A5 JP 2024099590A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- component
- bilberry
- dosage form
- oral dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000968 intestinal effect Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims 24
- 229930002877 anthocyanin Natural products 0.000 claims 8
- 235000010208 anthocyanin Nutrition 0.000 claims 8
- 239000004410 anthocyanin Substances 0.000 claims 8
- 150000004636 anthocyanins Chemical class 0.000 claims 8
- 244000078534 Vaccinium myrtillus Species 0.000 claims 6
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims 6
- 241000371652 Curvularia clavata Species 0.000 claims 5
- 240000001890 Ribes hudsonianum Species 0.000 claims 5
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims 5
- 235000001466 Ribes nigrum Nutrition 0.000 claims 5
- 239000006186 oral dosage form Substances 0.000 claims 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 240000005662 Aronia melanocarpa Species 0.000 claims 1
- 235000007425 Aronia melanocarpa Nutrition 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000015943 Coeliac disease Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 244000169938 Empetrum nigrum Species 0.000 claims 1
- 235000012778 Empetrum nigrum Nutrition 0.000 claims 1
- 208000037487 Endotoxemia Diseases 0.000 claims 1
- 206010061958 Food Intolerance Diseases 0.000 claims 1
- 206010017964 Gastrointestinal infection Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 206010025476 Malabsorption Diseases 0.000 claims 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 235000021014 blueberries Nutrition 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000021735 chronic enteritis Diseases 0.000 claims 1
- 208000019836 digestive system infectious disease Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000006549 dyspepsia Diseases 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 230000035699 permeability Effects 0.000 description 3
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024063716A JP2024099590A (ja) | 2016-10-27 | 2024-04-11 | 腸の健康を促す組成物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019545873A JP7011885B2 (ja) | 2016-10-27 | 2016-10-27 | 腸の健康を促す組成物 |
| PCT/US2016/059226 WO2018080510A1 (en) | 2016-10-27 | 2016-10-27 | Intestinal health promoting compositions |
| JP2021189726A JP7473516B2 (ja) | 2016-10-27 | 2021-11-22 | 腸の健康を促す組成物 |
| JP2024063716A JP2024099590A (ja) | 2016-10-27 | 2024-04-11 | 腸の健康を促す組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021189726A Division JP7473516B2 (ja) | 2016-10-27 | 2021-11-22 | 腸の健康を促す組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024099590A JP2024099590A (ja) | 2024-07-25 |
| JP2024099590A5 true JP2024099590A5 (https=) | 2024-11-08 |
Family
ID=62023893
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545873A Active JP7011885B2 (ja) | 2016-10-27 | 2016-10-27 | 腸の健康を促す組成物 |
| JP2021189726A Active JP7473516B2 (ja) | 2016-10-27 | 2021-11-22 | 腸の健康を促す組成物 |
| JP2024063716A Pending JP2024099590A (ja) | 2016-10-27 | 2024-04-11 | 腸の健康を促す組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545873A Active JP7011885B2 (ja) | 2016-10-27 | 2016-10-27 | 腸の健康を促す組成物 |
| JP2021189726A Active JP7473516B2 (ja) | 2016-10-27 | 2021-11-22 | 腸の健康を促す組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20190255134A1 (https=) |
| JP (3) | JP7011885B2 (https=) |
| KR (1) | KR20190079641A (https=) |
| CN (1) | CN110636760B (https=) |
| WO (1) | WO2018080510A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190079641A (ko) * | 2016-10-27 | 2019-07-05 | 엔에스이 프로덕츠, 인크. | 장 건강 촉진 조성물 |
| KR102178556B1 (ko) * | 2019-03-21 | 2020-11-13 | 강원대학교산학협력단 | 마늘껍질 추출물을 포함하는 장내균총 개선용 프리바이오틱스 조성물 및 이를 포함하는 기능성 식품 |
| FR3097122B1 (fr) * | 2019-06-11 | 2021-06-18 | Valbiotis | Melange d’extraits de plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l’intestin |
| CN110283754B (zh) * | 2019-07-11 | 2021-02-02 | 中国科学院北京基因组研究所 | 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群 |
| IT201900019325A1 (it) * | 2019-10-18 | 2021-04-18 | Ghs Gemelli Health System S R L | Miscela comprendente estratti di frutti, e polifenoli estratti da foglie o frutti di Olea Europaea L. e inulina e uso di tale composizione nel trattamento di malattie infiammatorie acute e croniche, localizzate o sistemiche, o conseguenti ad un’ischemia o a un’alterazione della funzionalità dell’endotelio vasale |
| US20230293482A1 (en) * | 2020-03-24 | 2023-09-21 | Shibaura Institute Of Technology | Central nervous system potentiating composition |
| KR20210156445A (ko) | 2020-06-18 | 2021-12-27 | 종근당건강 주식회사 | 들쭉나무 열매 분말 또는 추출물을 함유하는 장내 환경 개선용 조성물 |
| WO2022045211A1 (ja) * | 2020-08-25 | 2022-03-03 | 国立大学法人 熊本大学 | 月経に伴う不快状態の改善用組成物 |
| JP2023124967A (ja) * | 2022-02-28 | 2023-09-07 | アスパック企業株式会社 | 腸内環境改善剤 |
| CN115645429B (zh) * | 2022-12-12 | 2023-05-16 | 汤臣倍健股份有限公司 | 一种花色苷组合物及其应用 |
| KR20250167568A (ko) * | 2023-01-04 | 2025-12-01 | 엔에스이 프로덕츠, 인크. | 대사 건강 증진 조성물 |
| CN116790402B (zh) * | 2023-01-14 | 2024-05-14 | 西北农林科技大学 | 一株具有抗炎特性的单形拟杆菌菌株、培养方法及应用 |
| CN117085117B (zh) * | 2023-09-14 | 2024-03-12 | 浙江花开星辰生物科技有限公司 | 一种洋甘菊提取物的抗幽门螺旋杆菌组合物及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060123663A (ko) * | 1999-08-27 | 2006-12-01 | 미시간 스테이트 유니버시티 | 천연 사이클로옥시게나제 저해물질을 함유하는 조성물 |
| US8337914B2 (en) * | 2002-02-27 | 2012-12-25 | Access Business Group International Llc | Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation |
| JP2004099578A (ja) | 2002-09-04 | 2004-04-02 | Oriza Yuka Kk | 美肌用組成物 |
| US20070243268A1 (en) * | 2005-11-07 | 2007-10-18 | Jaffe Russell M | Compositions for regulating intestinal disorders and methods of use thereof |
| EP1882473A1 (en) * | 2006-07-28 | 2008-01-30 | Indena S.P.A. | Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs |
| JP2008271878A (ja) | 2007-04-27 | 2008-11-13 | Wakasa Seikatsu:Kk | 新規飲食品 |
| JP5877902B2 (ja) * | 2011-08-17 | 2016-03-08 | マイクロバイオーム セラピューティクス，エルエルシー | バクテロイデス門の胃腸管微生物相対フィルミクテス門の微生物相の比を上昇させるための組成物および製剤の使用 |
| EP2682005A1 (en) * | 2012-07-05 | 2014-01-08 | Symrise AG | A dietary supplement composition |
| EP2710901A1 (en) * | 2012-09-20 | 2014-03-26 | Symrise AG | Dietary supplement compositions |
| US20140128333A1 (en) * | 2012-11-02 | 2014-05-08 | Maqui New Life S.A. | Compounds, Compositions, and Methods for Decreasing Intestinal Glucose Uptake and Inducing Incretin Release |
| AU2014236655B2 (en) * | 2013-03-15 | 2017-06-29 | Mars, Incorporated | Edible pet chew and method of making the same |
| KR20190079641A (ko) | 2016-10-27 | 2019-07-05 | 엔에스이 프로덕츠, 인크. | 장 건강 촉진 조성물 |
-
2016
- 2016-10-27 KR KR1020197015224A patent/KR20190079641A/ko active Pending
- 2016-10-27 WO PCT/US2016/059226 patent/WO2018080510A1/en not_active Ceased
- 2016-10-27 JP JP2019545873A patent/JP7011885B2/ja active Active
- 2016-10-27 CN CN201680091887.7A patent/CN110636760B/zh active Active
- 2016-10-27 US US16/346,100 patent/US20190255134A1/en not_active Abandoned
-
2021
- 2021-11-22 JP JP2021189726A patent/JP7473516B2/ja active Active
-
2024
- 2024-04-11 JP JP2024063716A patent/JP2024099590A/ja active Pending
- 2024-08-12 US US18/801,755 patent/US20250114419A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024099590A5 (https=) | ||
| Li et al. | Lowering glycemic levels via gastrointestinal tract factors: the roles of dietary fiber, polyphenols, and their combination | |
| US11998558B2 (en) | Synthetic composition for treating antibiotic associated complications | |
| JP2015531770A5 (https=) | ||
| JP4282763B2 (ja) | 消化管内の微生物個体数の変更 | |
| JP2022036990A5 (https=) | ||
| Gassull | The role of nutrition in the treatment of inflammatory bowel disease | |
| Damianos et al. | Gut goo: physiology, diet, and therapy of intestinal mucus and biofilms in gastrointestinal health and disease | |
| Sun et al. | Metabolic regulation mechanism of fucoidan via intestinal microecology in diseases | |
| EP3131568B1 (en) | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders | |
| Peng et al. | Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease | |
| Ma et al. | The role of intestinal microbiota and metabolites in intestinal inflammation | |
| WO2009020595A2 (en) | Nutritional supplement system | |
| JP2020513014A5 (https=) | ||
| JP2019534331A5 (https=) | ||
| Wang et al. | Colonisation with endogenous Lactobacillus reuteri R28 and exogenous Lactobacillus plantarum AR17-1 and the effects on intestinal inflammation in mice | |
| Ren et al. | Advancement in therapeutic intervention of prebiotic-based nanoparticles for colonic diseases | |
| Cao et al. | Impact of dietary components on enteric infectious disease | |
| Ryu et al. | The current hepatic encephalopathy pipeline | |
| Patra et al. | Prebiotics as promising therapeutics for treating gut-related disorders: Biochemical and molecular perspectives | |
| CA3116039A1 (en) | Human dietary supplement and method for treating digestive system and immune-related disorders | |
| Zhang et al. | Dietary fibers: structural aspects and nutritional implications | |
| JP2025511131A5 (https=) | ||
| Kelly | Infectious diarrhoea | |
| JP2009519897A5 (https=) |